Dylan Drego – Page 5 – Wantai BioPharm

In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread

Hand, foot, and mouth disease (HFMD) is a reemerging illness caused by a variety of enteroviruses. The main causative agents are enterovirus 71 (EV71), coxsackievirus A16 (CVA16), and, most

Hepatitis E News Articles

Médecins Sans Frontières: “The End of Viral Hepatitis by 2030 Is Impossible Without Tackling Hepatitis E”

Soudan Du Sud -?In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis as a public health threat by 2030, focusing primarily on chronic hepatitis B and

Innovax News Articles

Continued: IVI and Innovax Launch Efforts to Make World’s First Hepatitis E Vaccine Available for Global Public Health

Xiamen,China – On first and second day of November of this year, the final meeting for assessment of Hepatitis E vaccine was held smoothly at INNOVAX. The outcome from the assessment was

EV-71 Scientific Articles

Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients

Abstract – Enterovirus A71 (EV-A71) is one of the main causative agents of hand, foot and mouth disease (HFMD). Unlike other enteroviruses that cause HFMD, EV-A71 is more frequently

Innovax News Articles

Mr. Steven Gao Elected as the DCVMN Executive Committee Member for the Fourth Consecutive Time

The general manager of INNOVAX – Mr. Steven Gao was elected to the new executive committee in the DCVMN Annual Meeting in Buenos Aires, Argentina, 26 Oct 2016. A total of seven executive

Innovax News Articles

IVI and Innovax Launch Efforts to Make World’s First Hepatitis E Vaccine Available for Global Public Health

Xiamen, China – The International Vaccine Institute (IVI) and Xiamen Innovax Biotech Co., Ltd. (Innovax) have entered a collaboration to make Hecolin?, the world’s first Hepatitis E vaccine,

Hepatitis E Scientific Articles

Long-Term Efficacy of a Hepatitis E Vaccine

Hepatitis E virus (HEV) is a common cause of acute hepatitis worldwide.1,2 HEV infection occurs in two distinct epidemiologic patterns.3 The most common pattern is waterborne infection, which is

Innovax News Articles

First Genital Warts Vaccine in China Starts the Phase I Clinical Trial

The Phase I clinical trial of the first genital warts vaccine (HPV 6/11 vaccine) in China is recently initiated in the Liuzhou city of Guangxi province, March 26, 2015. This HPV6/11 vaccine, with

Hecolin News Articles

WHO Strategic Advisory Group of Experts on Immunization Assessed Hecolin^® as a Promising Vaccine

In the meeting of Strategic Advisory Group of Experts (SAGE) on immunization on 21–23 October 2014 in Geneva, Switzerland, the SAGE Hepatitis E Working Group report to SAGE information on the

Innovax News Articles

Mr. Steven Gao Was Elected to the New DCVMN Executive Committee

The general manager of INNOVAX–Mr. Steven Gao was elected to the executive committee unanimously in the just concluded DCVMN Annual Meeting in New Delhi, India, 29 Oct 2014. A total of